Advertisement

Lipoproteins and Diet in the Pathogenesis of Atherosclerosis

  • James W. Anderson
  • Tammy L. Floore
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 273)

Abstract

Atherosclerotic cardiovascular disease is a major cause of mortality and morbidity in Western countries, leading to 759,000 deaths annually in the United States1. The pathogenesis of atherosclerosis is complex, multifactorial, and involves both environmental and genetic risk factors. Steinberg2 schematically illustrated the proposed interplay of blood factors with arterial wall responses (Figure 1). Since many of these factors are discussed elsewhere,3 this review will focus on the central role of lipoproteins in atherosclerosis. Specifically, this review will examine the evidence linking dietary cholesterol and fat intake to serum lipoproteins and coronary heart disease (CHD), the strength of the relationships between atherosclerosis and serum lipoproteins, clinical trials focusing on lowering serum lipoproteins to reduce risk for CHD, animal and human regression studies, the effects of dietary fiber on serum lipoproteins and CHD, and practical implications.

Keywords

Coronary Heart Disease Serum Cholesterol Dietary Fiber Coronary Heart Disease Risk Coronary Heart Disease Mortality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    U.S. Department of Health and Human Services, “The Surgeon General’s Report on Nutrition and Health,” U.S. Government Printing Office, Washington (1988).Google Scholar
  2. 2.
    D. Steinberg, Lipoproteins and atherosclerosis: a look back and a look ahead, Arteriosclerosis 3:283 (1983).PubMedCrossRefGoogle Scholar
  3. 3.
    J.W. Anderson, D.A. Deakins, T.L. Floore, B.M. Smith, and S.E. Whitis, Dietary fiber and coronary heart disease, CRC Reviews, in press.Google Scholar
  4. 4.
    N. N. Anitschkow, A history of experimentation on arterial atherosclerosis in animals, in: “Cowdry’s Arteriosclerosis: A Survey of the Problem,” C.C. Thomas, Springfield (1967).Google Scholar
  5. 5.
    M.G. Bond, B.C. Bullock, D.A. Bellinger, and T.E. Hamm, Myocardial infarction in a large colony on nonhuman primates with coronary artery atherosclerosis, Am. J. Pathol. 101:675 (1980).PubMedGoogle Scholar
  6. 6.
    R.W. Wissler, Principles of the pathogenesis of atherosclerosis, in: “Heart Disease: A Textbook of Cardiovascular Medicine,” E. Braunwald, ed., W.B. Saunders Company, Philadelphia (1984).Google Scholar
  7. 7.
    A. Keys, “Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease,” Harvard University Press, Cambridge (1980).Google Scholar
  8. 8.
    A.C. Arntzenius, D. Kromhout, J.D. Barth, J.H.C. Reiber, A.V.G. Bruschke, B. Buis, C.M. van Gent, N.Kempen-Voogd, S. Strikwerda, and E.A. van der Velde, Diet, lipoproteins, and the progression of coronary atherosclerosis New Engl. J. Med. 312:805 (1985).PubMedCrossRefGoogle Scholar
  9. 9.
    M.L. Armstrong, E.D. Warner, and W. E. Connor, Regression of coronary atheromatosis in Rhesus monkeys, Circulation Res. 27:59 (1970).PubMedGoogle Scholar
  10. 10.
    T.B. Clarkson, M.G. Bond, B. C. Bullock, K.J. McLaughlin, and J.K. Sawyer, A study of atherosclerosis regression in Macaca mulatta, Exp. Mol. Pathol. 41:96 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    C.J. Glueck, D.J. Gordon, J.J. Nelson, C.E. Davis, and H. A. Tyroler, Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial, Am. J. Clin. Nutr. 44:489 (1986).PubMedGoogle Scholar
  12. 12.
    F.M. Sacks, J. Salazar, L. Miller, J.M. Foster, M. Sutherland, K.W. Samonds, J.J. Albers, and E.H. Kass, Ingestion of egg raises plasma low density lipoproteins in free-living subjects, Lancet 1:647 (1984).PubMedCrossRefGoogle Scholar
  13. 13.
    J. Stamler and R. Shekelle, Dietary cholesterol and human coronary heart disease: the epidemiologic evidence, Arch. Pathol. Lab. Med. 112:1032 (1988).PubMedGoogle Scholar
  14. 14.
    W.E. Connor, and S.L. Connor, The key role of nutritional factors in the prevention of coronary heart disease, Prev. Med. 1:49 (1972).PubMedCrossRefGoogle Scholar
  15. 15.
    A. Keys, Diet, in: “Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease,” Harvard University Press, Cambridge (1980).Google Scholar
  16. 16.
    D.M. Hegsted, and L.M. Ausman, Diet, alcohol and coronary heart disease in men, J. Nutr. 118:1184 (1988).PubMedGoogle Scholar
  17. 17.
    Inter-Society Commission for Heart Disease Resources, Optimal resources for primary prevention of atherosclerotic disease, Circulation 70:153A (1984).CrossRefGoogle Scholar
  18. 18.
    J. Stamler, D. Wentworth, and J.D. Neaton, Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?, JAMA 256:2823 (1986).PubMedCrossRefGoogle Scholar
  19. 19.
    Consensus Conference, Lowering blood cholesterol to prevent heart disease, JAMA 253:2080 (1985).CrossRefGoogle Scholar
  20. 20.
    S.M. Grundy, Cholesterol and coronary heart disease: a new era, JAMA 256:2849 (1986).PubMedCrossRefGoogle Scholar
  21. 21.
    W.B. Kannel, W.P. Castelli and T. Gordon, Cholesterol in the prediction of atherosclerotic disease, Ann. Intern. Med. 90:85 (1979).PubMedGoogle Scholar
  22. 22.
    The Pooling Project Research Group, Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: Final report of the Pooling Project, J. Chron. Dis. 31:201 (1978).CrossRefGoogle Scholar
  23. 23.
    C. Aravanis, The classic risk factors for coronary heart disease: experience in Europe, Prev. Med. 12:16 (1983).PubMedCrossRefGoogle Scholar
  24. 24.
    N. Rifai, Lipoproteins and apolipoproteins: composition, metabolism and association with coronary heart disease. Arch. Pathol. Lab. Med. 110:694 (1986).PubMedGoogle Scholar
  25. 25.
    W. P. Castelli, J.T. Doyle, T. Gordon, C.G. Hames, M.C. Hjortland, S.B. Hulley, A. Kagan, and W.J. Zukel, HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study, Circulation 55:767 (1977).PubMedGoogle Scholar
  26. 26.
    The Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: reduction in incidence of coronary heart disease, JAMA 251:351 (1984).CrossRefGoogle Scholar
  27. 27.
    D.J. Gordon, and B.M. Rifkind, High-density lipoprotein — the clinical implications of recent studies, New Engl. J. Med. 321:1311 (1989).PubMedCrossRefGoogle Scholar
  28. 28.
    W.B. Kannel, High-density lipoproteins: epidemiologic profile and risks of coronary artery disease, Am. J. Cardiol. 52:9B (1983).PubMedCrossRefGoogle Scholar
  29. 29.
    H. Aberg, H. Lithell, I. Selinus, and H. Hedstrand, Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris, Atherosclerosis 54:89 (1985).PubMedCrossRefGoogle Scholar
  30. 30.
    T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber, High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study, Am. J. Med. 62:707 (1977).PubMedCrossRefGoogle Scholar
  31. 31.
    K.M. West, M.M.S. Ahuja, P.H. Bennett, A. Czyzyk, O. Mateo De Acosta, J.H. Fuller, B. Grab, V. Grabauskas, R.J. Jarrett, K. Kosaka, H. Keen, A.S. Krolewski, E. Miki, V. Schliack, A. Teuscher, P.J. Watkins, and J.A. Stober, The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial diseae in nine diabetic population samples from the WHO multinational study, Diabetes Care 6:361 (1983).PubMedCrossRefGoogle Scholar
  32. 32.
    D.B. Zilversmit, Atherogenesis: a postprandial phenomenon, Circulation 60:473 (1979).PubMedGoogle Scholar
  33. 33.
    B.H. Chung, J.P. Segrest, K. Smith, F.M. Griffin, and C.G. Brouillette, Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein, J. Clin. Invest. 83:1363 (1989).PubMedCrossRefGoogle Scholar
  34. 34.
    J.S. Cohn, J.R. McNamara, S.D. Cohn, J.M. Ordovas, and E.J. Schaefer, Postprandial plasma lipoprotein changes in human subjects of different ages, J. Lipid Res. 29:469 (1988).PubMedGoogle Scholar
  35. 35.
    R.J. Havel, Early effects of fat ingestion on lipids and lipoproteins of serum in man, J. Clin. Invest. 36:848 (1957).PubMedCrossRefGoogle Scholar
  36. 36.
    T.G. Redgrave, and L.A. Carlson, Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man, J. Lipid Res. 20:217 (1979).PubMedGoogle Scholar
  37. 37.
    G.R. Castro, and C.J. Fielding, Effects of postprandial lipemia on plasma cholesterol metabolism, J. Clin. Invest. 75:874 (1985).PubMedCrossRefGoogle Scholar
  38. 38.
    I. Hjermann, K. Velve Byre, I. Holmf, P. Leren, Effect of diet and smoking intervention on the incidence of coronary heart disease, Lancet 2:1303 (1981).PubMedCrossRefGoogle Scholar
  39. 39.
    Lipid Research Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251:365 (1984).CrossRefGoogle Scholar
  40. 40.
    M.H. Frick, O. Elo, K. Haapa, O.P. Heinonen, P. Heinsalmi, P. Helo, J.K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, H. Maenpaa, M. Malkonen, M. Manttari, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjoblom, and E.A. Nikkila, Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia, N. Engl. J. Med. 317:1237 (1987).PubMedCrossRefGoogle Scholar
  41. 41.
    Committee of Principal Investigators, A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate, Br. Heart J. 40:1069 (1978).CrossRefGoogle Scholar
  42. 42.
    L. Wilhelmsen, G. Berglund, D. Elmfeldt, G. Tibblin, H. Wedel, K. Pennert, A. Vedin, C. Wilhelmsson, and L. Werko, The multifactor primary prevention trial in Goteborg, Sweden, Eur. Heart J. 7:279 (1986).PubMedGoogle Scholar
  43. 43.
    D.H. Blankenhorn, S.A. Nessim, R. L. Johnson, M.E. Sanmarco, S.P. Azen, and L. Cashin-Hemphill, Beneficial effects of combined Colestipol-Niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA 257:3233 (1987).PubMedCrossRefGoogle Scholar
  44. 44.
    B.G. Brown, E.L. Bolson, C.D. Pierce, R.B. Peterson, and H.T. Dodge, Regression of atherosclerosis in man: current data and their methodological limitations, in: “Regression of Atherosclerotic Lesions - Experimental Studies and Observations in Humans,” M. R. Malinow and V. H. Blaton, eds., Plenum Press, New York (1984).Google Scholar
  45. 45.
    D.H. Blankenhorn, R.L. Johnson, W.J. Mack, H.A. El Zein, and L. I. Vailas, The influence of diet on the appearance of new lesions in human coronary arteries, JAMA 263:1646 (1990).PubMedCrossRefGoogle Scholar
  46. 46.
    C.J. Lavie, G.T. Gau, R.W. Squires, and B. A. Kottke, Management of lipids in primary and secondary prevention of cardiovascular diseases. Mayo Clin. Proc. 63:605 (1988).PubMedGoogle Scholar
  47. 47.
    J.F.Brensike, R.I. Levy, S.F. Kelsey, E.R. Passamani, J.M. Richardson, I.K. Loh, N.J. Stone, R.F. Aldrich, J.W. Battaglini, D. J. Moriarty, M.R. Fisher, L. Friedman, W. Friedewald, K.M. Detre, and S.E. Epstein, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study, Circulation 69:313 (1984).PubMedCrossRefGoogle Scholar
  48. 48.
    A. Keys, F. Grande, and J.T. Anderson, Fiber and pectin in the diet and serum cholesterol concentration in man, Proc. Soc. Exp. Biol. Med. 106:555 (1961).PubMedGoogle Scholar
  49. 49.
    J.E. Garvin, D.T. Forman, W.R. Eiseman, and C.R. Phillips, Lowering of human serum cholesterol by an oral hydrophylic colloid, Proc. Soc. Exp. Biol. Med. 120:744 (1965).PubMedGoogle Scholar
  50. 50.
    J.W. Anderson, N. Zettwoch, T. Feldman, J. Tietyen-Clark, P. Oeltgen, and C.W. Bishop, Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men, Arch. Intern. Med. 148:292 (1988).PubMedCrossRefGoogle Scholar
  51. 51.
    A.P. DeGroot, R. Luyken, and N.A. Pikaar, Cholesterol-lowering effect of rolled oats, Lancet 2:303 (1963).CrossRefGoogle Scholar
  52. 52.
    D.J.A. Jenkins, D. Reynolds, B. Slavin, A.R. Leeds, A.L. Jenkins, and E.M. Jepson, Dietary fiber and blood lipids: treatment of hypercholesterolemia with guar crispbread, Am. J. Clin. Nutr. 33:575 (1980).PubMedGoogle Scholar
  53. 53.
    J.W. Anderson, and N. J. Gustafson, Alternative lipid-lowering diets, Practical Cardiology 14:84 (1988).Google Scholar
  54. 54.
    J.W. Anderson, L. Story, B. Sieling, W.-J.L. Chen, M.S. Petro, and J. Story, Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men, Am. J. Clin. Nutr. 40:1146 (1984).PubMedGoogle Scholar
  55. 55.
    J.W. Anderson, W.-J.L. Chen, and B. Sieling, Hypolipidemic effects of high-carbohydrate, high-fiber diets, Metabolism 29:551 (1980).PubMedCrossRefGoogle Scholar
  56. 56.
    T. Gordon, A. Kagan, M. Garcia-Palmieri, W.B. Kannel, W.J. Zukel, J. Tillotson, P. Sorlie, and M. Hjortland, Diet and its relation to coronary heart disease and death in three populations, Circulation 63:500 (1981).PubMedCrossRefGoogle Scholar
  57. 57.
    M.R. Garcia-Palmieri, P. Sorlie, J. Tillotson, R. Costas, E. Cordero, and M. Rodriguez, Relationship of dietary intake to subsequent coronary heart disease incidence: the Puerto Rico Heart Health Program, Am. J. Clin. Nutr. 33:1818 (1980).PubMedGoogle Scholar
  58. 58.
    D.L. McGee, D.M. Reed, K. Yano, A. Kagan, and J. Tillotson, Ten-year incidence of coronary heart disease in the Honolulu Heart Program, Am. J. Epidemiol. 119:667 (1984).PubMedGoogle Scholar
  59. 59.
    J.W. Anderson, Plant fiber and blood pressure, Ann. Intern. Med. 98:842 (1983).PubMedGoogle Scholar
  60. 60.
    J.W. Anderson and K. Ward, High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus, Am. J. Clin. Nutr. 32:2312 (1979).PubMedGoogle Scholar
  61. 61.
    H.C.R. Simpson, R.W. Simpson, S. Lousley, R.D. Carter, M. Geekie, T.D.R. Hockaday, and J.I. Mann, A high carbohydrate leguminous fibre diet improves all aspects of diabetic control, Lancet 1:1 (1981).PubMedCrossRefGoogle Scholar
  62. 62.
    L. Story, J.W. Anderson, W.-J.L. Chen, D. Karounos, and B. Jefferson, Adherence to high-carbohydrate, high-fiber diets: long-term studies of non-obese diabetic men, J. Am. Diet. Assoc. 85:1105 (1985).PubMedGoogle Scholar
  63. 63.
    M. Krotkiewski, Effect of guar gum on body-weight, hunger ratings and metabolism in obese subjects, Br. J. Nutr. 52:97 (1984).PubMedCrossRefGoogle Scholar
  64. 64.
    J.W. Anderson, and C.A. Bryant, Dietary fiber: diabetes and obesity, Am. J. Gastroenterol. 81:898 (1986).PubMedGoogle Scholar
  65. 65.
    D. Kromhout, E.B. Bosschieter, and C.D.L. Coulander, Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes, Lancet 2:518 (1982).PubMedCrossRefGoogle Scholar
  66. 66.
    J.N. Morris, J.W. Marr, and D.G. Clayton, Diet and heart: a postscript, Br. Med. J. 2:1307 (1977).PubMedCrossRefGoogle Scholar
  67. 67.
    L.H. Kushi, R.A. Lew, F.J. Stare, C.R. Ellison, M.E. Lozy, G. Bourke, L. Daly, I. Graham, N. Hickey, R. Mulcahy, and J. Kevaney, Diet and 20-year mortality from coronary heart Disease. The Ireland-Boston Diet-Heart Study, New Engl. J. Med. 312:811 (1985).PubMedCrossRefGoogle Scholar
  68. 68.
    K.-T. Khaw and E. Barrett-Connor, Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study, Am. J. Epidemiol. 126:1093 (1987).PubMedGoogle Scholar
  69. 69.
    J. Hallfrisch, J. D. Tobin, D. C. Muller, and R. Andres, Fiber Intake, Age, and Other Coronary Risk Factors in Men of the Baltimore Longitudinal Study (1959–1975), J. Gerontology: Med. Sci. 43:M64 (1988).Google Scholar
  70. 70.
    D. Kromhout and C. de Lezenne Coulander, Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men: the Zutphen Study, Am. J. Epidemiol. 119:733 (1984).PubMedGoogle Scholar
  71. 71.
    The Expert Panel, Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults, Arch. Intern. Med. 148:36 (1988).CrossRefGoogle Scholar
  72. 72.
    Study Group, European Atherosclerosis Society, Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society, Eur. Heart J. 8:77 (1987).Google Scholar
  73. 73.
    The Canadian Consensus Conference on the Prevention of Heart and Vascular Disease by Altering Serum Cholesterol and Lipoprotein Risk Factors, Canadian Consensus Conference on Cholesterol: A final report, Can. Med. Assoc. J. 139:1 (1988).Google Scholar
  74. 74.
    A Joint Statement of the Nutrition Committee and the Council on Arteriosclerosis, Recommendations for treatment of hyperlipidemia in adults, Circulation 69:1065A (1984).Google Scholar
  75. 75.
    L.-G. Ekelund, W.L. Haskell, J.L. Johnson, F.S. Whaley, M.H. Criqui, and D.S. Sheps, Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men, N.Engl. J. Med. 319:1379 (1988).PubMedCrossRefGoogle Scholar
  76. 76.
    P.D. Wood, W.L. Haskell, H. Klein, S. Lewis, M.P. Stern, and J.W. Farquhar, The distribution of plasma lipoproteins in middle-aged male runners, Metabolism 25:1249 (1976).PubMedCrossRefGoogle Scholar
  77. 77.
    J.W. Anderson, W.-J.L. Chen, and B. Sieling, Hypolipidemic effects of high-carbohydrate, high-fiber diets, Metabolism 29:551 (1980).PubMedCrossRefGoogle Scholar
  78. 78.
    J.W. Anderson, and N.J. Gustafson, Dietary fiber and heart disease: current management concepts and recommendations, Top. Clin. Nutr. 3:21 (1988).Google Scholar
  79. 79.
    J.W. Anderson, “Be Heart Smart”, The HCF Nutrition Research Foundation, Inc., Lexington (1989).Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • James W. Anderson
    • 1
  • Tammy L. Floore
    • 1
  1. 1.Metabolic Research Group, V.A. Medical CenterUniversity of KentuckyLexingtonUSA

Personalised recommendations